Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
A research team led by Prof. YAO Hongbin from the University of Science and Technology of China (USTC), in collaboration with Prof. SHANG Cheng from Fudan University and Prof. TAO Xinyong at Zhejiang ...
(Nanowerk News) Many substances with different chemical and physical properties, from diamonds to graphite, are made up of carbon atoms. Amorphous forms of solid carbon do not have a fixed crystal ...
image: Many substances with different chemical and physical properties, from diamonds to graphite, are made up of carbon atoms. Amorphous forms of solid carbon do not have a fixed crystal structure ...
Low solubility and bioavailability challenges are prevalent, necessitating early selection of appropriate drug delivery technologies to optimize clinical and commercial success. Amorphous solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback